-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I0a4/FSvvHaRmrYRFCQOuBloVfjL9k51k42DHHQ6y+RHAWFLcnyqa9snxaVnSWWS Q4sEjJttK5AIfdtoTVzsRg== 0001104659-08-073579.txt : 20081126 0001104659-08-073579.hdr.sgml : 20081126 20081126155436 ACCESSION NUMBER: 0001104659-08-073579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081124 FILED AS OF DATE: 20081126 DATE AS OF CHANGE: 20081126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Andrew Kenneth William CENTRAL INDEX KEY: 0001304113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19612 FILM NUMBER: 081217957 BUSINESS ADDRESS: BUSINESS PHONE: 215-579-7388 MAIL ADDRESS: STREET 1: C/O COLLAGENEX PHARMACEUTICALS, INC. STREET 2: 41 UNIVERSITY DRIVE CITY: NEWTOWN STATE: PA ZIP: 18940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMCLONE SYSTEMS INC CENTRAL INDEX KEY: 0000765258 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042834797 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 180 VARICK STREET - 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 646-638-5078 MAIL ADDRESS: STREET 1: 180 VARICK STREET - 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: IMCLONE SYSTEMS INC/DE DATE OF NAME CHANGE: 19940211 4 1 a4.xml 4 X0303 4 2008-11-24 0 0000765258 IMCLONE SYSTEMS INC IMCL 0001304113 Powell Andrew Kenneth William IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET NEW YORK NY 10014 0 1 0 0 SVP, General Counsel Stock Options (Right to Buy) 64.09 2008-11-24 4 D 0 60000 D 2018-08-11 Common Stock 60000 0 D These options were cancelled immediately prior to the merger of Alaska Acquisition Corp. with and into ImClone Systems Incorporated for a cash payment per underlying share equal to the difference between the exercise price and $70.00 GREGORY T. MAYES, BY POWER OF ATTORNEY 2008-11-26 -----END PRIVACY-ENHANCED MESSAGE-----